Document Detail


Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages.
MedLine Citation:
PMID:  20932867     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
CD36 is a scavenger receptor known to play a critical role in the development of atherosclerosis by mediating the uptake of oxidized low-density lipoproteins (oxLDL) by macrophages, thus leading to foam cell formation. It is now generally recognized that the immune system has a pivotal role in the pathogenesis of atherosclerosis, whose progression is determined by ongoing inflammatory reactions. Recently, several studies pointed out that opioid peptides exert anti-inflammatory activities. Therefore the aim of the present study was to evaluate a possible endomorphin-1 (EM-1) immunomodulatory activity on human foam cells. Our results showed that EM-1 reduced Nile Red-stained lipid droplets content, decreased the expression of CD36 receptor and modulated tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) release from lipid-laden macrophages. Furthermore, Naloxone, an opioid receptors antagonist, reverted the anti-atherogenic and anti-inflammatory observed effects of EM-1. These data demonstrated, for the first time, an unprecedented ability of EM-1 to act as a novel modulator for macrophage-to-foam cell transformation, and for inflammatory cytokines profile, suggesting possible novel endomorphin-based anti-atherosclerotic approaches for the prevention and treatment of atherosclerosis.
Authors:
Valerio Chiurchiù; Valerio Izzi; Fabiola D'Aquilio; Daniela Vismara; Felicia Carotenuto; Giuseppina Catanzaro; Mauro Maccarrone
Related Documents :
19286587 - Immune response in human cerebral cavernous malformations.
19631027 - Mechanisms linking osteoporosis with cardiovascular calcification.
19723077 - Apoptosis does not mediate macrophage depletion in rabbit atherosclerotic plaques after...
18536737 - Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chron...
19629637 - Suppressive effect of dexamethasone on timp-1 production involves murine osteoblastic m...
21250837 - Heterologous immunity: immunopathology, autoimmunity and protection during viral infect...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-13
Journal Detail:
Title:  Peptides     Volume:  32     ISSN:  1873-5169     ISO Abbreviation:  Peptides     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8008690     Medline TA:  Peptides     Country:  United States    
Other Details:
Languages:  eng     Pagination:  80-5     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Laboratory of Lipid Neurochemistry, European Center for Brain Research (CERC)/IRCCS Fondazione S.Lucia, Via del Fosso di Fiorano 65, 00143 Rome, Italy. valchiu@yahoo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Skin peptide and cDNA profiling of Australian anurans: genus and species identification and evolutio...
Next Document:  Investigation of endogenous soybean food allergens by using a 2-dimensional gel electrophoresis appr...